Different Resistance Mutations Can be Detected Simultaneously in the Blood and the Lung of HIV-1 Infected Individuals on Antiretroviral Therapy

Journal of Medical Virology

Volumn 72, Issue 3, 2004, Pages 352-357

  White, Natalie C ^a   Israel Biet, Dominique ^b   Coker, Richard J ^a   Mitchell, David M ^a   Weber, Jonathan N ^a   Clarke, John R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Brochoalveolar lavage; Discordant mutations; Drug resistance; HIV 1; Lung

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; DNA; LAMIVUDINE; LOVIRIDE; NUCLEOSIDE DERIVATIVE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD; CONTROLLED STUDY; DISEASE ASSOCIATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG; LUNG LAVAGE; NONHUMAN; PLASMA; RETROSPECTIVE STUDY; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRONCHOALVEOLAR LAVAGE FLUID; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG; MUTATION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1642539192     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20010     Document Type: Article

References (34)

1. Aquaro S, Perno CF, Balestra E, Balzarini J, Cenci A, Francesconi M, Panti S, Serra F, Villani N, Calio R. 1997. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative in lymphocytes. J Leukoc Biol 62:138-143.
2. Atkins M, Strappe P, Kaye S, Loveday C, McLaughlin JE, Johnson MA, Tedder RS, Griffiths PD, Emery VC. 1998. Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients. J Med Virol 55:138-146.
3. Beck JM, Rosen M, Peavy HH. 2001. Pulmonary complications of HIV infection: Report on the fourth NHLBI workshop. Am J Respir Crit Care Med 164:2120-2126.
4. Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC. 1986. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA 256:2356-2359.
5. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
6. Clarke JR, Krishnan V, Bennett J, Mitchell D, Jeffries DJ. 1990. Detection of HIV-1 in human lung macrophages using the polymerase chain reaction. AIDS 4:1133-1136.
7. Clarke JR, Taylor IK, Fleming J, Nukuna A, Williamson JD, Mitchell DM. 1993. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS 7:555-560.
8. Clarke JR, Israel-Biet D. 1996. Interactions between opportunistic micro-organisms and HIV in the lung. Thorax 51:773-775.
9. Clarke JR, Mitchell DM, Coker RJ, Israel-Biet D. 1998. Is the lung a privileged site for the human immunodeficiency virus? Thorax 53:81-82.
10. Delwart EL, Mullins JI, Gupta P, Learn GHJ, Holodniy M, Katzenstein D, Walker BD, Sing MK. 1998. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 72:617-623.
11. Di Stefano M, Sabri F, Leitner T, Svennerholm B, Hagberg L, Norkrans G, Chiodi F. 1995. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J Clin Microbiol 33:352-355.
12. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
13. Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM. 1999. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [see comments]. N Engl J Med 340:1614-1622.
14. Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD. 2000. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [see comments]. JAMA 283:229-234.
15. Israel-Biet D, Cadrenal J, Evan P. 1993. Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. Am Rev Respir Dis 148:1308-1312.
16. Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. 1994. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 91:11378-11382.
17. Jeffrey AA, Israel-Biet D, Andrieu JM, Even P, Venet A. 1991. HIV isolation from pulmonary cells derived from bronchoalveolar lavage. Clin Exp Immunol 84:488-492.
18. Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin JF. 1994. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 10:72-78.
19. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. 1998. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals . AIDS 12:719-727.
20. Linnemann CCJ, Baughman RP, Frame PT, Floyd R. 1989. Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS. Chest 96:64-67.
21. Nakata K, Weiden M, Harkin T, Ho D, Rom WN. 1995. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: Evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1:744-757.
22. Orenstein J, Fox C, Wahl SM. 1997. Macrophages as a source of HIV during opportunistic infection. Science 276:1857-1861.
23. Poss M, Martin HL, Kreiss JK, Granville L, Chohan B, Nyange P, Mandaliya K, Overbaugh J. 1995. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 69:8118-8122.
24. Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM. 1991. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis 143:850-854.
25. Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Verhofstede C, Rimland D, Schinazi RF, Rossau R. 1997. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 41:284-291.
26. Taylor IK, Coker RJ, Clarke J, Moss FM, Nieman R, Evans DJ, Veale D, Shaw RJ, Robinson DS, Mitchell DM. 1995. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-1993. Thorax 50:1240-1245.
27. Twigg HL, Soliman DM, Day RB, Knox KS, Anderson RJ, Wilkes DS. 1999. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 159:1439-1444.
28. van't Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schultemaker H. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 72:488-496.
29. Wahl SM, Greenwall-Wild T, Peng G, Hale-Donze H, Orenstein JM. 1999. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Inf Dis 179:S457-S460.
30. White NC, Agostini C, Israel-Biet D, Semenzato G, Clarke JR. 1999. The growth and control of human immunodeficiency virus in the lung: Implications for highly active antiretroviral therapy. Eur J Clin Invest 29:964-972.
31. Wolff AJ, O'Donnell AE. 2001. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001:1888-1893.
32. Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD. 1997a. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 94:12574-12579.
33. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. 1997b. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues. J Virol 71:2059-2071.
34. Young B, Johnson S, Bahktiari M, Shugarts D, Young RK, Allen M, Ramey RR, Kuritzkes DR. 1998. Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure. J Infect Dis 178:1497-1501.